Estradiol/Progesterone (Bijuva) for Menopausal Vasomotor Symptoms

Date: July 1, 2019 Issue #: 1575Summary: The FDA has approvedBijuva (TherapeuticsMD), a fixed-dose combination of estradiol and progesterone, for oral treatment of moderate to severe vasomotor symptoms (hot flashes) due to menopause in women with an intact uterus. The manufacturer is marketingBijuva as " the first and only FDA-approved combination of bio-identical estradiol and bio-identical progesterone in a single daily oral capsule " .

http://secure.medicalletter.org/TML-article-1575b

Source: The Medical Letter - May 29, 2019 Category: Drugs & Pharmacology Authors: admin Tags: Activella Alora Angeliq bazedoxifene Bijuva Bioidentical Hormones Climara Combi-Patch Divigel Drospirenone Duavee Elestrin Estrogens Evamist femhrt Femring Hot flashes Medroxyprogesterone Menest Menopause Premarin Source Type: research